Muhammad Junaid Tariq
Clinical Assisstant Professor
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (1)
Chimeric antigen receptor (CAR) T cell therapies have revolutionized B cell malignancy treatment, but subsets of patients with large B cell lymphoma (LBCL) experience primary resistance or relapse after CAR T cell treatment. To uncover tumor microenvironment (TME)-induced resistance mechanisms, we examined patients’ intratumoral immune infiltrates and observed that elevated levels of immunoregulatory macrophages in pre-infusion tumor biopsies are correlated with poor clinical responses. CAR T cell-produced interferon-gamma (IFN-γ) promotes the expression of inducible nitric oxide synthase (iNOS, NOS2) in immunoregulatory macrophages, impairing CAR T cell function. Mechanistically, iNOS-expressing macrophages upregulated the p53 pathway, mediating apoptosis and cell cycle arrest in CAR T cells, while downregulating the MYC pathway involved in ribosome biogenesis and protein synthesis. Furthermore, CAR T cell metabolism is compromised by depletion of glycolytic intermediates and rewiring of the TCA cycle. Pharmacological inhibition of iNOS enhances the CAR T cell treatment efficacy in B cell tumor-bearing mice. Notably, elevated levels of iNOS+CD14+ monocytes were observed in leukaphereses of patients with non-durable response to CAR T cell therapy. These findings suggest that mitigating iNOS in tumor-associated macrophages (TAMs) by blocking IFN-γ secretion from CAR T cells will improve outcomes for LBCL patients.
Year:
2025
Collaborators (8)
Yun Pyo Kang
Assistant Professor
Seoul National University
Xuefeng Wang
Associate Member/Professor
H Lee Moffitt Cancer Center and Research Institute
Marco Davila
SVP, Translational Research
Roswell Park Comprehensive Cancer Center
Jianmin Wang
Associate Professor
Roswell Park Comprehensive Cancer Center
Hiroshi Kotani
Professor and Cairman
University of the Ryukyus
Timothy Shaw
Assistant Member/Professor
Moffitt Cancer Center
Michael Jain
Associate Member
H Lee Moffitt Cancer Center and Research Institute
Paulo Rodriguez
Senior Member-Professor
H Lee Moffitt Cancer Center and Research Institute
Make your next move.
Prepare your application
Review drafts before you send them.